Se-Natal 19 Chewable Tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Se-Natal 19 Chewable Tablets are also useful in improving the nutritional status of women prior to conception.
One tablet daily, or as directed by a physician.
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F)[See USP controlled room temperature].
A Prescription Prenatal Vitamin with other Vitamins and Minerals for Nutritional Supplementation
Rx Only
Se·Natal 19 Chewable tablets are round, debossed "TL015." These tablets provide oil-soluble vitamins, water-soluble vitamins and minerals. Each tablet contains:
| Servings per Bottle: | 100 | %DV For Pregnant and Lactating Women |
| Serving Size | 1 chewable tablet | |
| Each Tablet contains: | ||
Vitamin A (as beta carotene) | 1000 IU | 23% |
| Vitamin C (calcium ascorbate) | 100 mg | 83% |
| Vitamin D (as cholecalciferol) | 10 mcg | 67% |
| Vitamin E (as dl-alpha tocopherol acetate) | 30 IU | 142% |
| Thiamine (Vitamin B1) | 3 mg | 214% |
| Riboflavin (Vitamin B2) | 3 mg | 188% |
| Niacin (as niacinamide) | 15 mg | 83% |
| Vitamin B6 (as pyridoxine HCl) | 20 mg | 1000% |
| Folate (folic acid) | 1000 mcg | 167% |
| Vitamin B12 (as cyanocobalamin) | 12 mcg | 429% |
| Pantothenic Aicd (as calcium pantothenate) | 7 mg | 100% |
| Calcium (as calcium carbonate) | 200 mg | 15% |
| Iron (as ferrous fumarate) | 29 mg | 107% |
| Zinc (as zinc oxide) | 20 mg | 154% |
Oral iron is absorbed most efficiently when administered between meals. Iron is critical for normal hemogloblin syntheis to maintain oxygen transport, energy production and proper function of cells. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes, which are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Deficiency of folic acid may account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megablastic macrocytic anemias. Vitamin B12 is essential to growth cell reproduction, hematopoiesis, nucleic acid, and myelin synthesis. Deficiency may result in megaloblastic anemia or pernicious anemia.
Acacia, Fumed Silica, Magnesium Stearate, Natural Orange Flavour, Orange Juice Powder, Stearic Acid, Stevia, Sucrose.
Se-Natal 19 Chewable Tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Se-Natal 19 Chewable Tablets are also useful in improving the nutritional status of women prior to conception.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia. In that hematologic remission can occur while neurological manifestations remain progressive.
Safety and effectiveness in pediatric patients have not been established.
Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
Adverse reactions with iron therapy may include GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Prescriber should be aware of a number of iron/drug interactions, including antacids, tetracyclines, or fluoroquinolones.
Abdominal pain, metabolic acidosis, anuria, CNS damage, coma, convulsions, death, dehydration, diffuse vascular congestion, hepatic cirrhosis, hypotension, hypothermia, lethargy, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, tachycardia, hyperglycemia, drowsiness, pallor, cyanosis, lassitude, seizures, and shock.
One tablet daily, or as directed by a physician.
Contact with moisture can discolor or erode the tablet.
Se-Natal 19 Chewable Tablets for oral administration are supplied as multi-color-speckled, round tablets debossed "TL015," packaged in bottles of 100 tablets.
Product Code: 13925-117-01
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F)[See USP controlled room temperature].
Dispense in a tight, light-resistant container as defined in the USP/INF with child-resistant closure.
Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Reserved for Professional
Recommendation.
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
Rx Only
Manufactured For:
Seton Pharmaceuticals
Manasquan, NJ 08736
1-800-510-3401
MADE IN CANADA
Code 640138
Rev. 03/24
SETON PHARMACEUTICALS
NDC 13925-117-01
Se-Natal 19 Chewable Tablets
A Prescription Prenatal Vitamin with other Vitamins and Minerals for Nutritional Supplementation
Rx Only
100 Tablets
SETON
PHARMACEUTICALS
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13925-117-01 | 2024-02-01 | C162847 | 48780-1 | d6a99b39-6a33-a426-e053-dadaa90af4c2 | Se-Natal 19 Chewable Tablets |
| 13925-117-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-6a33-a426-e053-dadaa90af4c2 | Se-Natal 19 Chewable Tablets |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13925-117-01 | Se-Natal 19 Chewable | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13925-117-01 | EA - Each | 13925-117 | 26e64bae-b379-40fe-9547-06e9946b6fe4 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL ACETATE, DL- | ACTIVE INGREDIENT | WR1WPI7EW8 | 2 | |
| BETA CAROTENE | ACTIVE INGREDIENT | 01YAE03M7J | 2 | |
| CALCIUM ASCORBATE | ACTIVE INGREDIENT | 183E4W213W | 2 | |
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 2 | |
| CALCIUM PANTOTHENATE | ACTIVE INGREDIENT | 568ET80C3D | 2 | |
| CHOLECALCIFEROL | ACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| CYANOCOBALAMIN | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| FERROUS FUMARATE | ACTIVE INGREDIENT | R5L488RY0Q | 2 | |
| FOLIC ACID | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| PYRIDOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 68Y4CF58BV | 2 | |
| RIBOFLAVIN | ACTIVE INGREDIENT | TLM2976OFR | 2 | |
| THIAMINE MONONITRATE | ACTIVE INGREDIENT | 8K0I04919X | 2 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| .ALPHA.-TOCOPHEROL, DL- | ACTIVE MOIETY | 7QWA1RIO01 | 2 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| BETA CAROTENE | ACTIVE MOIETY | 01YAE03M7J | 2 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 2 | |
| CHOLECALCIFEROL | ACTIVE MOIETY | 1C6V77QF41 | 2 | |
| CYANOCOBALAMIN | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| FERROUS CATION | ACTIVE MOIETY | GW89581OWR | 2 | |
| FOLIC ACID | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| NIACINAMIDE | ACTIVE MOIETY | 25X51I8RD4 | 2 | |
| PANTOTHENIC ACID | ACTIVE MOIETY | 19F5HK2737 | 2 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| RIBOFLAVIN | ACTIVE MOIETY | TLM2976OFR | 2 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 2 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| ORANGE JUICE | INACTIVE INGREDIENT | 5A9KE2L9L3 | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| STEVIA REBAUDIUNA LEAF | INACTIVE INGREDIENT | 6TC6NN0876 | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13925-117 | 13925-117-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ORANGE JUICE | ORANGE JUICE | 5A9KE2L9L3 | SOLUTION / ORAL | NA | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, CHEWABLE / ORAL | 121 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, CHEWABLE / ORAL | 121 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| ORANGE JUICE | ORANGE JUICE | 5A9KE2L9L3 | SOLUTION / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Se-Natal 19 Chewable | VITAMINS AND MINERALS | Seton Pharmaceuticals | a54dd642-8884-415a-a082-cd9fb544e400 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 13925-117-01 13925-117 13925011701 b623b8b8-5503-4354-9bfd-4610257ceb87 a54dd642-8884-415a-a082-cd9fb544e400 |
Adverse event summaries are temporarily unavailable. Other product information remains available.